News Details

Rubius Therapeutics to Present Preclinical Data for RTX-321, a Red Cell Therapeuticâ„¢ Oncology Product Candidate for HPV-Positive Cancers at the American Association of Cancer Research Annual Meeting

About Rubius Therapeutics, Inc.

Price Chart